Skip to main content
. 2012 Feb 15;2(2):130–140.

Figure 3.

Figure 3

RAD001 treatment inhibits thyroid tumor cell proliferation of ThrbPV/PVPten+/- mice. (A). Representative microphotographs of Ki-67 immunohisto-chemistry on thyroid sections of placebo (control; panel a) and RAD001-treated ThrbPV/PVPten+/- mice (panel b). (B). Thyroid cell proliferative index, determined by Ki-67 immunohistochemistry in the control and treated groups, shows a significant reduction in the percentage of proliferating cells in the thyroids of RAD001-treated ThrbPV/PVPten+/- mice (open bar) as compared with placebo-treated ThrbPV/PVPten+/- mice (closed bar) [56].